Silence Therapeutics PLC (SLN) — Free Cash Flow Generation Index
Silence Therapeutics PLC (SLN) has a Free Cash Flow Generation Index of 0.98x as of June 2021. Free cash flow of $25.59 Million represents 1% of operating cash flow ($26.03 Million). Read total liabilities of Silence Therapeutics PLC for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Silence Therapeutics PLC Free Cash Flow Generation Index (2019–2021)
Historical FCF Generation Index trend for Silence Therapeutics PLC across 2 annual periods. Explore Silence Therapeutics PLC (SLN) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Silence Therapeutics PLC (2019–2021)
Year-by-year Free Cash Flow Generation Index for Silence Therapeutics PLC. For the full company profile including market capitalisation, see SLN market cap.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.80x | $7.39 Million | $9.19 Million | $1.80 Million | ▼ -19.2% |
| 2019 | 0.99x | $1.72 Million | $1.73 Million | $9.00K | — |